Automated Digital Imaging for Cervical Cancer Screening
用于宫颈癌筛查的自动数字成像
基本信息
- 批准号:10634569
- 负责人:
- 金额:$ 51.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-06 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcetic AcidsAddressAlgorithmsAutomobile DrivingBiological AssayBiopsyCellular PhoneCervicalCervical Cancer ScreeningCervical Intraepithelial NeoplasiaCervix UteriCharacteristicsClassificationClinicalCollaborationsColposcopesColposcopyCytologyDNADataDevelopmentDiagnosisEffectivenessFDA approvedGeneral PopulationGenerationsGoalsHIVHealth ServicesHigh PrevalenceHistologicHuman Papilloma Virus VaccineHuman PapillomavirusHuman papilloma virus infectionImageImaging technologyIncidenceIndiaInfrastructureInvestigationLesionLicensingMalignant NeoplasmsMalignant neoplasm of cervix uteriMarketingMethodsModelingMorbidity - disease rateOutputPerformancePredictive ValuePrevalencePricePrimary PreventionProceduresProviderQualifyingRecommendationReportingResourcesRiskSafetySecondary PreventionServicesSouth AfricaSouth AfricanSpecificityTestingTimeTriageUniversitiesVisitVisualWomanWomen&aposs GroupWorkWorld Health Organizationantiretroviral therapyautomated visual evaluationclinical research sitecloud basedcostcost effectivecost effectivenessdigitaldigital imagingeffectiveness studyhigh risk populationhistological specimensimplementation evaluationimprovedlow and middle-income countriesmachine learning algorithmmortalitynew technologypoint of careprogramsrandomized, clinical trialsrecruitscreeningscreening programscreening servicessuccess
项目摘要
Project Abstract/Summary:
Cervical cancer screening programs remain essential to reduce cervical cancer in women despite
the availability of human papilloma virus (HPV) vaccines. Screening is important for all women
but is particularly important for women living with HIV given the high prevalence of HPV in this
group and risks associated with progression notwithstanding antiretroviral therapy. Here we
propose to investigate the clinical utility of a new method of automated digital imaging of the cervix
on the MobileODT platform as a screen-and-treat approach. We build on a long-term collaboration
between the University of Cape Town and Columbia University investigating how to strengthen
cervical cancer screening and treatment in South Africa. Currently, screen-and-treat programs
utilizing HPV DNA testing are recommended by the World Health Organization. We have
demonstrated the safety, efficacy and cost-effectiveness of this approach for the South African
setting with its high HIV prevalence in women. In this setting, we are currently completing an NCI-
supported study demonstrating the feasibility and outstanding performance of an HPV DNA assay
that can be used at the point-of-care for a single-visit, screen-and-treat program. Here we propose
to extend this work to investigate in Specific Aim 1: the performance characteristics of automated
digital imaging as a standalone, primary screening test to replace HPV DNA testing for use in the
single-visit, screen-and-treat approach; Specific Aim 2: the performance characteristics of
automated digital imaging as a triage test for women who test HPV DNA positive in the screen-
and-treat approach; and Specific Aim 3: facility-level operational challenges and facilitators to
integrating this new imaging technology into single-visit screen-and-treat programs. We propose
to undertake the studies to address these aims among women living with and without HIV at
clinical sites in Cape Town, South Africa. Our overall goal is to strengthen cervical cancer
screening approaches to reduce cost and improve the effectiveness of screening.
项目摘要/摘要:
尽管
人乳头瘤病毒(HPV)疫苗的可用性。筛查对所有女性都很重要
但鉴于HPV的高流行,对于艾滋病毒妇女尤为重要
尽管有抗逆转录病毒疗法,但与进展有关的组和风险。我们在这里
建议研究子宫颈自动化数字成像的新方法的临床实用性
在MobileDT平台上作为屏幕和治疗方法。我们以长期合作为基础
在开普敦大学和哥伦比亚大学之间调查如何加强
南非的宫颈癌筛查和治疗。目前,屏幕和处理程序
世界卫生组织建议使用HPV DNA测试。我们有
证明了这种方法对南非的安全性,功效和成本效益
以其女性的艾滋病毒率高而设定。在这种情况下,我们目前正在完成NCI-
支持的研究证明了HPV DNA分析的可行性和出色性能
可以在单访,屏幕和治疗程序的临界点上使用。我们在这里提出
扩展这项工作以在特定目标中进行调查1:自动化的性能特征
数字成像作为独立的主要筛选测试,以取代HPV DNA测试以用于
单访问,屏幕和治疗方法;特定目标2:性能特征
自动数字成像作为分类测试,用于在屏幕中测试HPV DNA阳性的女性
和治疗方法;和特定目标3:设施级的运营挑战和促进者
将这种新成像技术集成到单访问的屏幕和处理程序中。我们建议
进行研究以解决与艾滋病毒的妇女之间的这些目标
南非开普敦的临床场所。我们的总体目标是增强宫颈癌
筛选方法降低成本并提高筛查的有效性。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assessment of the implementation context in preparation for a clinical study of machine-learning algorithms to automate the classification of digital cervical images for cervical cancer screening in resource-constrained settings.
- DOI:10.3389/frhs.2022.1000150
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Castor, Delivette;Saidu, Rakiya;Boa, Rosalind;Mbatani, Nomonde;Mutsvangwa, Tinashe E M;Moodley, Jennifer;Denny, Lynette;Kuhn, Louise
- 通讯作者:Kuhn, Louise
Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening.
- DOI:10.1158/1055-9965.epi-21-0972
- 发表时间:2022-03-01
- 期刊:
- 影响因子:0
- 作者:Johnson LG;Saidu R;Svanholm-Barrie C;Boa R;Moodley J;Tergas A;Persing D;Campbell SA;Tsai WY;Wright TC;Denny L;Kuhn L
- 通讯作者:Kuhn L
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Louise Kuhn其他文献
Louise Kuhn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Louise Kuhn', 18)}}的其他基金
Automated Digital Imaging for Cervical Cancer Screening
用于宫颈癌筛查的自动数字成像
- 批准号:
10414907 - 财政年份:2020
- 资助金额:
$ 51.65万 - 项目类别:
Automated Digital Imaging for Cervical Cancer Screening
用于宫颈癌筛查的自动数字成像
- 批准号:
10082877 - 财政年份:2020
- 资助金额:
$ 51.65万 - 项目类别:
Automated Digital Imaging for Cervical Cancer Screening
用于宫颈癌筛查的自动数字成像
- 批准号:
10210372 - 财政年份:2020
- 资助金额:
$ 51.65万 - 项目类别:
Oral microbial signatures in perinatal HIV infection
围产期艾滋病毒感染的口腔微生物特征
- 批准号:
10197099 - 财政年份:2018
- 资助金额:
$ 51.65万 - 项目类别:
Improving specificity of HPV Screen-and-Treat in South Africa
提高南非 HPV 筛查和治疗的特异性
- 批准号:
8789475 - 财政年份:2014
- 资助金额:
$ 51.65万 - 项目类别:
Improving specificity of HPV Screen-and-Treat in South Africa
提高南非 HPV 筛查和治疗的特异性
- 批准号:
8929184 - 财政年份:2014
- 资助金额:
$ 51.65万 - 项目类别:
Improving specificity of HPV Screen-and-Treat in South Africa
提高南非 HPV 筛查和治疗的特异性
- 批准号:
9339765 - 财政年份:2014
- 资助金额:
$ 51.65万 - 项目类别:
Host epigenetic and mitochondrial function in HIV-infected children
HIV感染儿童的宿主表观遗传和线粒体功能
- 批准号:
8703154 - 财政年份:2012
- 资助金额:
$ 51.65万 - 项目类别:
相似国自然基金
钴活化过氧乙酸定向生成四价钴降解水中有机新污染物的机制与效能
- 批准号:42307072
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
产氢产乙酸菌和乙酸产甲烷菌细胞膜脂质响应高氨胁迫的分子机制及调控研究
- 批准号:52300172
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
缺陷型C3N5锚定钴单原子活化过氧乙酸降解典型新污染物机制
- 批准号:52370028
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
小热休克蛋白Hsp26调控K.marxianus发酵米酸汤高产乙酸乙酯机理研究
- 批准号:32360568
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
溶解性有机质介导亚铁/过氧乙酸还原—氧化协同深度矿化石化废水POPs的过程与机制
- 批准号:22308382
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
加强肯尼亚艾滋病毒阳性女性的宫颈癌筛查采用和治疗联系 (eCASCADE-Kenya)
- 批准号:
10738134 - 财政年份:2023
- 资助金额:
$ 51.65万 - 项目类别:
Tools for reversible short-term degradation of TCF-1 to address its molecular functions
用于 TCF-1 可逆短期降解以解决其分子功能的工具
- 批准号:
10647571 - 财政年份:2023
- 资助金额:
$ 51.65万 - 项目类别:
RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial)
重新利用抗逆转录病毒疗法来消除宫颈癌(POLESA 试验)
- 批准号:
10738121 - 财政年份:2023
- 资助金额:
$ 51.65万 - 项目类别: